Company (NASDAQ: WAY) insider Matthew Hawkins details option exercise and stock sales
Rhea-AI Filing Summary
WAY insider Matthew J. Hawkins filed to sell common stock under a Rule 144 framework. The filing lists a proposed sale of 22,462 common shares, expected to be issued from an exercise of stock options on 08/11/2026, with a proposed aggregate value of $554,811.40. It also details several recent 10b5-1 plan sales of common shares over the prior three months, indicating ongoing, pre-arranged selling activity.
Positive
- None.
Negative
- None.
Key Figures
Planned shares to be sold: 22,462 shares
Planned aggregate sale value: $554,811.40
10b5-1 sale on 07/16/2026: 36,901 shares for $851,944.46
+2 more
5 metrics
Planned shares to be sold
22,462 shares
Common stock from exercise of stock options expected 08/11/2026
Planned aggregate sale value
$554,811.40
Proposed sale of 22,462 common shares on 08/11/2026
10b5-1 sale on 07/16/2026
36,901 shares for $851,944.46
Common stock sold under 10b5-1 plan
10b5-1 sale on 07/15/2026
33,099 shares for $762,031.66
Common stock sold under 10b5-1 plan
Sale on 06/09/2026
47,754 shares for $918,309.42
Common stock sale listed outside 10b5-1 description line
Key Terms
10b5-1, Exercise of Stock Options, Executive Financial Services
3 terms
10b5-1 regulatory
"10b5-1 Sales for MATTHEW J HAWKINS 1550 Digital Drive"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Exercise of Stock Options financial
"Common | 08/11/2026 | Exercise of Stock Options | Issuer"
Executive Financial Services financial
"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What stock sale is disclosed for WAY insider Matthew J. Hawkins?
Matthew J. Hawkins plans to sell 22,462 common shares of WAY, tied to an exercise of stock options on 08/11/2026, with a proposed aggregate sale value of $554,811.40.
What non-10b5-1 WAY stock sale by Matthew J. Hawkins is reported?
The filing notes a sale of 47,754 common shares on 06/09/2026 for total proceeds of $918,309.42, listed separately from the 10b5-1 plan transactions for Matthew J. Hawkins.
Which broker is associated with the planned WAY stock sale?
The proposed sale of 22,462 WAY common shares is associated with Morgan Stanley Smith Barney LLC Executive Financial Services, listed at 1 New York Plaza, 8th Floor, New York, NY 10004.